GNLX - Genelux Corp
IEX Last Trade
2.14
0.160 7.477%
Share volume: 387,626
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.98
0.16
8.08%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-15 | 2023-08-14 | 2023-11-14 | 2024-03-29 | 2024-05-09 | |
| Cash flow financing | 14.640 M | 22.616 M | 6.363 M | 401.000 K | 688.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -4.590 M | -5.418 M | -3.357 M | -6.910 M | -4.354 M | |
| Net income | -10.364 M | -5.821 M | -5.345 M | -6.767 M | -7.850 M | |
| Depreciation | 136.000 K | 135.000 K | 133.000 K | 95.000 K | 84.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -109.000 K | -396.000 K | -277.000 K | -13.942 M | -1.691 M | |
| Net Borrowings | -10.391 M | -28.618 M | -31.139 M | -24.203 M | -21.204 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -109.000 K | -396.000 K | -277.000 K | -243.000 K | -30.000 K | |
| Cash Change | 10.338 M | 27.140 M | 29.869 M | 23.191 M | 19.627 M |